Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Licensing delineates helper and effector NK cell subsets during viral infection
Anthony E. Zamora, Ethan G. Aguilar, Can M. Sungur, Lam T. Khuat, Cordelia Dunai, G. Raymond Lochhead, Juan Du, Claire Pomeroy, Bruce R. Blazar, Dan L. Longo, Jeffrey M. Venstrom, Nicole Baumgarth, William J. Murphy
Anthony E. Zamora, Ethan G. Aguilar, Can M. Sungur, Lam T. Khuat, Cordelia Dunai, G. Raymond Lochhead, Juan Du, Claire Pomeroy, Bruce R. Blazar, Dan L. Longo, Jeffrey M. Venstrom, Nicole Baumgarth, William J. Murphy
View: Text | PDF
Research Article Immunology Inflammation

Licensing delineates helper and effector NK cell subsets during viral infection

  • Text
  • PDF
Abstract

Natural killer (NK) cells can be divided into phenotypic subsets based on expression of receptors that bind self-MHC-I molecules, a concept termed licensing or education. Here we show NK cell subsets with different migratory, effector, and immunoregulatory functions in dendritic cell and antigen (ag)-specific CD8+ T cell responses during influenza and murine cytomegalovirus infections. Shortly after infection, unlicensed NK cells localized in draining lymph nodes and produced GM-CSF, which correlated with the expansion and activation of dendritic cells, and resulted in greater and sustained ag-specific T cell responses. In contrast, licensed NK cells preferentially migrated to infected tissues and produced IFN-γ. Importantly, human NK cell subsets exhibited similar phenotypic characteristics. Collectively, our studies demonstrate a critical demarcation between the functions of licensed and unlicensed NK cell subsets, with the former functioning as the classical effector subset and the latter as the stimulator of adaptive immunity helping to prime immune responses.

Authors

Anthony E. Zamora, Ethan G. Aguilar, Can M. Sungur, Lam T. Khuat, Cordelia Dunai, G. Raymond Lochhead, Juan Du, Claire Pomeroy, Bruce R. Blazar, Dan L. Longo, Jeffrey M. Venstrom, Nicole Baumgarth, William J. Murphy

×

Figure 2

Adoptively transferred unlicensed NK cells preferentially traffic to draining lymph nodes following viral infection.

Options: View larger image (or click on image) Download as PowerPoint
Adoptively transferred unlicensed NK cells preferentially traffic to dra...
(A) Schema of adoptive transfer study where 20 × 106 splenocytes from naive CD45.1 congenic mice were i.v. adoptively transferred to naive C57BL/6 (CD45.2) recipients. Two days after adoptive transfer, recipient mice were challenged with either 100 PFU of APR8 in 40 μl of PBS or 40 μl of PBS (control) intranasally (i.n.). Five days later, the absolute number of donor (CD45.1) NK cells in the mediastinal lymph nodes (mLNs), nondraining lymph nodes (ndLNs), and lung were determined. (B) Absolute number of transferred (CD45.1+) NK cells (CD3-NK1.1+) in the mLNs, ndLNs, or lung of C57BL/6 (CD45.2) mice at 5 days postinfection (d.p.i.). (C) Absolute number of transferred (CD45.1+) licensed or unlicensed NK cell subsets in the mLNs of C57BL/6 (CD45.2) mice at 5 d.p.i. (D) Absolute number of transferred (CD45.1+) licensed or unlicensed NK cell subsets in the lung of C57BL/6 (CD45.2) mice at day 5 d.p.i. (E) Schema of adoptive transfer study where C57BL/6 (CD45.2) mice were challenged with 100 PFU of APR8 in 40 μl of PBS or 40 μl of PBS (control) i.n. One day later, 20 × 106 splenocytes from naive CD45.1 congenic mice were i.v. adoptively transferred to challenged C57BL/6 (CD45.2) recipients. One and 3 days after adoptive transfer, the absolute number of donor (CD45.1) NK cells in the mLNs was determined. (F) Absolute number of transferred (CD45.1+) licensed or unlicensed NK cell subsets in the mLN of C57BL/6 (CD45.2) mice at 1 and 3 d.p.i. (G) Histograms showing the level of Ki-67 of transferred (CD45.1+) NK cells in the mLNs of C57BL/6 (CD45.2) mice at 1 and 3 d.p.i. Three-day concanavalin A (Con A)–stimulated splenocytes were included as a positive control. (H) Absolute number of licensed or unlicensed NK cell subsets that express the chemokine receptor CXCR3 in the spleen, lung, or liver of naive C57BL/6 (H2b) mice. (I) Absolute number of NK cell subsets (CD3–NK1.1+Ly49C/I+G2+A+, Ly49C/I+G2+A–, Ly49C/I+G2–A+, Ly49C/I+G2–A–, Ly49C/I–G2+A+, Ly49C/I–G2+A–, Ly49C/I–G2–A+, or Ly49C/I–G2–A–) that express CXCR3 in the spleen of naive C57BL/6 mice. (J) Absolute number of licensed or unlicensed NK cell subsets that express CXCR3 in the spleen of naive B10.D2 (H2d) mice. n = 3–6 mice per group, representative of 2 to 3 experiments. (C, D, and F) Two-way ANOVA with Tukey post-test used to compare groups. (B, H, and J) Unpaired 2-tailed Student’s t test used to compare groups. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts